🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical trial is to learn about the interaction of sis...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2018-11-07
Trial ID
NCT03782662
Treatments Being Tested
This is a 2-part, open label, fixed-sequence study to evaluate the potentia...
Status
Completed
Location
Clinical Trial Site
Start Date
2021-06-07
Trial ID
NCT04933682
Treatments Being Tested
The purpose of this study is to investigate the drug interaction between fo...
Status
Completed
Location
Research Site
Start Date
2011-04
Trial ID
NCT01336218
Treatments Being Tested
The phase 1 portion of the study is designed to evaluate the safety, tolera...
Status
Active Not Recruiting
Location
OrsoBio Auckland Research Site 1
Start Date
2023-04-22
Trial ID
NCT05822544
Studies evaluating the effects of itraconazole or rifampicin on the pharmac...
Status
Completed
Location
Yali Liu
Start Date
2024-03-12
Trial ID
NCT06255951
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested
The main purpose of this study is to learn about how itraconazole and rifam...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2020-02-12
Trial ID
NCT05134337
Treatments Being Tested
This study will be conducted in a single center, open-label study with a si...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-10
Trial ID
NCT02975440
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2015-02
Trial ID
NCT02342886
This is a bioequivalence trial to evaluate the bioequivalence of Myrin P Fo...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-07
Trial ID
NCT01399788
Treatments Being Tested